Question

Difficulty: MediumDiagnostic Workup and Test Sequencing

A previously healthy 4242-year-old man visits a new primary care provider to establish medical care. He reports feeling unusually fatigued over the last few months, accompanied by frequent muscle cramps in his legs and an increase in nighttime urination. He has not seen a physician in five years and currently takes no medications. His blood pressure is 172/104172/104 mmHg, and his heart rate is 7878/min. Physical examination reveals normal heart sounds, clear lungs, and no abdominal bruits. Laboratory testing shows the following:

TestValue
Sodium145145 mEq/L
Potassium2.82.8 mEq/L
Chloride102102 mEq/L
Bicarbonate3131 mEq/L
Creatinine0.90.9 mg/dL

Which of the following is the most appropriate next step in the diagnostic evaluation of this patient?

  1. Measurement of plasma aldosterone-to-renin ratioAnswer
  2. B
    Intravenous saline infusion test
  3. C
    Computed tomography scan of the abdomen
  4. D
    Adrenal venous sampling
  5. E
    Renal artery duplex ultrasonography

Answer

Measurement of plasma aldosterone-to-renin ratio
The correct answer is measurement of the plasma aldosterone-to-renin ratio. This patient presents with the classic triad of primary hyperaldosteronism: severe hypertension, spontaneous hypokalemia, and metabolic alkalosis. The Endocrine Society guidelines mandate a strict stepwise diagnostic approach. The first step is always biochemical screening using the plasma aldosterone concentration (PAC) to plasma renin activity (PRA) ratio. A high ratio (typically > 2020) with an elevated PAC (> 1515 ng/dL) suggests autonomous aldosterone production (primary hyperaldosteronism), while a low ratio suggests secondary hyperaldosteronism (e.g., renal artery stenosis).

Step-by-Step Solution

1
Identify the primary clinical syndrome from the patient's presentation and laboratory results.
The patient presents with severe hypertension, spontaneous hypokalemia (2.82.8 mEq/L), and metabolic alkalosis (bicarbonate 3131 mEq/L) in the absence of diuretic use.
Recognizing this classic triad is essential to formulate a differential diagnosis that prioritizes hyperaldosteronism.
2
Determine the initial diagnostic priority for the suspected condition.
The clinician must differentiate between primary hyperaldosteronism (Conn syndrome) and secondary hyperaldosteronism (e.g., renal artery stenosis).
These etiologies require fundamentally different downstream testing and management algorithms.
3
Select the appropriate guideline-recommended initial test.
The plasma aldosterone-to-renin ratio (ARR) is chosen as the first step.
The ARR is the most reliable, non-invasive first-line screening tool to establish the biochemical presence of primary hyperaldosteronism.

Key Concept

The initial step in evaluating suspected primary hyperaldosteronism (suggested by hypertension, hypokalemia, and metabolic alkalosis) is biochemical screening with the plasma aldosterone-to-renin ratio.
Rate this question